Biology subjects

Haas, C. M.

Publications and source records attributed to Haas, C. M..

4 recordsLinked to original sources

bioRxiv2026

Reliable and Efficient Agentic Protein Design with Toolset Harnessing

Computational protein design workflows require the orchestration of multiple tools, data formats, and analysis steps that are often fragmented. Here, we introduce Chaperone, a lightweight and customizable framework that enables seamless integration of RFdiffusion3 (RFD3) with downstream sequence design, structure prediction, and evaluation tools, including ProteinMPNN, AlphaFold3 (AF3), and more than 50 other protein design tools. By combining a programmable agent-friendly interface with parallelized execution on high-performance computing systems, Chaperone as a harness enables rapid iteration and scalable exploration of complex protein design workflows. Across an evaluation of nine biomolecular design tasks, we find using Chaperone reduces total token usage relative to baseline agents by 86% and GPU costs by 64%, while increasing the overall computational design pass rate. We demonstrate Chaperones utility for large-scale design-space exploration through a two-week end-to-end small-molecule binder design campaign, yielding low nanomolar binders to cortisol zero shot. We further demonstrate its versatility across distinct design challenges, including the design of a symmetric 12-subunit self-assembly nanoparticle and a linker that mediates interactions between C2- and D3-symmetric protein complexes to form crystalline assemblies. Together, these results demonstrate how agent harnesses built around standardized tool interfaces can substantially improve the efficiency and success of complex, long-horizon agentic design workflows in biology. We make Chaperone freely available to the community on GitHub: https://github.com/RosettaCommons/chaperone.

biochemistry↗

bioRxiv2025

De novo design of protein nanoparticles with integrated functional motifs

Computational design of self-assembling proteins has long relied on pre-existing structures and sequences, fundamentally limiting control over their structural and functional properties. Recent machine learning-based methods have transformed our ability to design functional small de novo proteins and oligomers, yet methods to design large de novo protein assemblies with structures tailored to specific applications are still underexplored. Here, we develop a generalizable method for designing de novo symmetric protein complexes that incorporate target functional motifs into their structures. We report 34 new protein nanoparticles that form on-target assemblies with cubic point group symmetries. The nanoparticles exhibit a wide variety of backbones that were designed with atom-level accuracy, as evidenced by several cryo-EM and crystal structures that reveal minimal deviations from the design models. We use the method to generate a de novo antigen-tailored nanoparticle vaccine that elicits robust immune responses in mice. These results establish a generalizable approach that can be used to design functional self-assembling protein complexes with structures tailored to specific applications.

biochemistry↗

bioRxiv2025

From sequence to scaffold: computational design of protein nanoparticle vaccines from AlphaFold2-predicted building blocks

Self-assembling protein nanoparticles are being increasingly utilized in the design of next-generation vaccines due to their ability to induce antibody responses of superior magnitude, breadth, and durability. Computational protein design offers a route to novel nanoparticle scaffolds with structural and biochemical features tailored to specific vaccine applications. Although strategies for designing new self-assembling proteins have been established, the recent development of powerful machine learning-based tools for protein structure prediction and design provides an opportunity to overcome several of their limitations. Here, we leveraged these tools to develop a generalizable method for designing novel self-assembling proteins starting from AlphaFold2 predictions of oligomeric protein building blocks. We used the method to generate six new 60-subunit protein nanoparticles with icosahedral symmetry, and single-particle cryo-electron microscopy reconstructions of three of them revealed that they were designed with atomic-level accuracy. To transform one of these nanoparticles into a functional immunogen, we reoriented its termini through circular permutation, added a genetically encoded oligomannose-type glycan, and displayed a stabilized trimeric variant of the influenza hemagglutinin receptor binding domain through a rigid de novo linker. The resultant immunogen elicited potent receptor-blocking and neutralizing antibody responses in mice. Our results demonstrate the practical utility of machine learning-based protein modeling tools in the design of nanoparticle vaccines. More broadly, by eliminating the requirement for experimentally determined structures of protein building blocks, our method dramatically expands the number of starting points available for designing new self-assembling proteins. Significance StatementSelf-assembling protein nanoparticle vaccines have steadily gained traction in both academic and industry vaccine development over the last decade. Recent work has shown that computationally designing new self-assembling proteins allows the structural and functional features of nanoparticle vaccines to be precisely tailored, and that this can significantly affect the vaccine-elicited immune response. To date, designing such nanoparticle vaccines has required the use of known crystal structures as starting points. Here we show how new machine learning tools can be leveraged to design new self-assembling protein nanoparticle immunogens in the absence of experimentally determined structures of the building blocks that elicit strong immune responses in mice.

biochemistry↗

bioRxiv2021

One-shot identification of SARS-CoV-2 S RBD escape mutants using yeast screening

The potential emergence of SARS-CoV-2 Spike (S) escape mutants is a threat to reduce the efficacy of existing vaccines and neutralizing antibody (nAb) therapies. An understanding of the antibody/S escape mutations landscape is urgently needed to preemptively address this threat. Here we describe a rapid method to identify escape mutants for nAbs targeting the S receptor binding site. We identified escape mutants for five nAbs, including three from the public germline class VH3-53 elicited by natural COVID-19 infection. Escape mutations predominantly mapped to the periphery of the ACE2 recognition site on the RBD with K417, D420, Y421, F486, and Q493 as notable hotspots. We provide libraries, methods, and software as an openly available community resource to accelerate new therapeutic strategies against SARS-CoV-2. One Sentence SummaryWe present a facile method to identify antibody escape mutants on SARS-CoV-2 S RBD.

biochemistry↗